The Efficacy and Safety of a Variable Square Pulse (VSP) Erbium:YAG Laser for Treatment of Enlarged Pores in Asians.
dilated pores
enlarged pores
erbium:YAG laser
facial pores
laser treatment
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
28
09
2020
received:
24
06
2020
accepted:
15
10
2020
pubmed:
9
11
2020
medline:
29
10
2021
entrez:
8
11
2020
Statut:
ppublish
Résumé
Enlarged pores are one of the most common causes of skin surface irregularities. Existing studies supporting the benefit of lasers and energy-based devices (EBD) for this condition are limited, with a short duration of follow-up period. We aimed to evaluate the efficacy and adverse effects of Er:YAG laser for treatment of enlarged pores in dark-skinned patients. Nineteen subjects (aged 26-47 years) with skin phototypes III (21.1%) and IV (78.9%) and enlarged pores were treated with 4 monthly sessions of Erbium:YAG laser. Objective (ultraviolet light A video camera) and subjective (clinical evaluation by two blinded dermatologists) assessments were obtained at baseline, 1-month after each treatment and at 1, 3, and 6 months after the final treatment. The weighted mean score of quartile grading scales showed significant improvement in pore size from baseline starting at 1-month after the third treatment and continued until 3 months after the fourth (final) treatment (P < 0.001). However, the improvement dropped significantly at 6 months after the final treatment. Objective measurements of the improvements in skin surface smoothness and wrinkles corresponded with the physician raters' clinical evaluation. Erbium:YAG laser is a safe and effective treatment for enlarged pores in dark-skinned individuals. Maintenance treatments are recommended to achieve a longer-lasting outcome. Lasers Surg. Med. © 2020 Wiley Periodicals LLC.
Sections du résumé
BACKGROUND AND OBJECTIVES
Enlarged pores are one of the most common causes of skin surface irregularities. Existing studies supporting the benefit of lasers and energy-based devices (EBD) for this condition are limited, with a short duration of follow-up period. We aimed to evaluate the efficacy and adverse effects of Er:YAG laser for treatment of enlarged pores in dark-skinned patients.
STUDY DESIGN/MATERIALS AND METHODS
Nineteen subjects (aged 26-47 years) with skin phototypes III (21.1%) and IV (78.9%) and enlarged pores were treated with 4 monthly sessions of Erbium:YAG laser. Objective (ultraviolet light A video camera) and subjective (clinical evaluation by two blinded dermatologists) assessments were obtained at baseline, 1-month after each treatment and at 1, 3, and 6 months after the final treatment.
RESULTS
The weighted mean score of quartile grading scales showed significant improvement in pore size from baseline starting at 1-month after the third treatment and continued until 3 months after the fourth (final) treatment (P < 0.001). However, the improvement dropped significantly at 6 months after the final treatment. Objective measurements of the improvements in skin surface smoothness and wrinkles corresponded with the physician raters' clinical evaluation.
CONCLUSIONS
Erbium:YAG laser is a safe and effective treatment for enlarged pores in dark-skinned individuals. Maintenance treatments are recommended to achieve a longer-lasting outcome. Lasers Surg. Med. © 2020 Wiley Periodicals LLC.
Substances chimiques
Erbium
77B218D3YE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-621Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Kim BY, Choi JW, Park KC, Youn SW. Sebum, acne, skin elasticity, and gender difference-Which is the major influencing factor for facial pores? Skin Res Technol 2013;19(1):e45-e53.
Lee SJ, Seok J, Jeong SY, Park KY, Li K, Seo SJ. Facial pores: Definition, causes, and treatment options. Dermatol Surg 2016;42(3):277-285.
Sugata K, Nishijima T, Kitahara T, Takema Y. Confocal laser microscopic imaging of conspicuous facial pores in vivo: Relation between the appearance and the internal structure of skin. Skin Res Technol 2008;14(2):208-212.
Al-Dhalimi M, Jaber A. Treatment of atrophic facial acne scars with fractional Er:Yag laser. J Cosmet Laser Ther 2015;17(4):184-188.
Lee SJ, Kang JM, Chung WS, Kim YK, Kim HS. Ablative non-fractional lasers for atrophic facial acne scars: A new modality of erbium:YAG laser resurfacing in Asians. Lasers Med Sci 2014;29(2):615-619.
Manuskiatti W, Iamphonrat T, Wanitphakdeedecha R, Eimpunth S. Comparison of fractional erbium-doped yttrium aluminum garnet and carbon dioxide lasers in resurfacing of atrophic acne scars in Asians. Dermatol Surg 2013;39(1 Pt 1):111-120.
Reinholz M, Schwaiger H, Heppt MV, et al. Comparison of two kinds of lasers in the treatment of acne scars. Facial Plast Surg 2015;31(5):523-531.
Heinrich U, Tronnier H, Stahl W, Bejot M, Maurette JM. Antioxidant supplements improve parameters related to skin structure in humans. Skin Pharmacol Physiol 2006;19(4):224-231.
Sugiyama-Nakagiri Y, Sugata K, Iwamura M, Ohuchi A, Kitahara T. Age-related changes in the epidermal architecture around facial pores. J Dermatol Sci 2008;50(2):151-154.
Sugiyama-Nakagiri Y, Sugata K, Hachiya A, Osanai O, Ohuchi A, Kitahara T. Ethnic differences in the structural properties of facial skin. J Dermatol Sci 2009;53(2):135-139.
Roh M, Han M, Kim D, Chung K. Sebum output as a factor contributing to the size of facial pores. Br J Dermatol 2006;155(5):890-894.
Li ZJ, Park SB, Sohn KC, et al. Regulation of lipid production by acetylcholine signalling in human sebaceous glands. J Dermatol Sci 2013;72(2):116-122.
Gunduz O, Aytekin A. Trichostasis spinulosa confirmed by standard skin surface biopsy. Int J Trichol 2012;4(4):273-274.
Manuskiatti W, Tantikun N. Treatment of trichostasis spinulosa in skin phototypes III, IV, and V with an 800-nm pulsed diode laser. Dermatol Surg 2003;29(1):85-88.
Dong J, Lanoue J, Goldenberg G. Enlarged facial pores: An update on treatments. Cutis 2016;98(1):33-36.
Schmults CD, Phelps R, Goldberg DJ. Nonablative facial remodeling: Erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol 2004;140(11):1373-1376.
Cho SB, Noh S, Lee SJ, Kang JM, Kim YK, Lee JH. Combination of Q-switched and quasi long-pulsed 1064-nm Nd:YAG laser, non-ablative 1450-nm diode laser, and ablative 10 600-nm carbon dioxide fractional laser for enlarged pores. J Dermatolog Treat 2010;21(4):258-260.
Chung H, Goo B, Lee H, Roh M, Chung K. Enlarged pores treated with a combination of Q-switched and micropulsed 1064 nm Nd:YAG laser with and without topical carbon suspension: A simultaneous split-face trial. Laser Ther 2011;20(3):181-188.
Kim JE, Lee HW, Kim JK, et al. Objective evaluation of the clinical efficacy of fractional radiofrequency treatment for acne scars and enlarged pores in Asian skin. Dermatol Surg 2014;40(9):988-995.
Lee CN, Kim YJ, Lee HS, Kim HS. Effects of Q-switched and long-pulsed 1064 nm Nd:YAG laser on enlarged facial pores. Photodermatol Photoimmunol Photomed 2009;25(6):328-330.
Lee HJ, Lee KR, Park JY, Yoon MS, Lee SE. The efficacy and safety of intense focused ultrasound in the treatment of enlarged facial pores in Asian skin. J Dermatolog Treat 2015;26(1):73-77.
Roh MR, Chung HJ, Chung KY. Effects of various parameters of the 1064 nm Nd:YAG laser for the treatment of enlarged facial pores. J Dermatolog Treat 2009;20(4):223-228.
Yim S, Lee YH, Choi YJ, Kim WS. Split-face comparison of the picosecond 1064-nm Nd:YAG laser using a microlens array and the quasi-long-pulsed 1064-nm Nd:YAG laser for treatment of photoaging facial wrinkles and pores in Asians. Lasers Med Sci 2020;35(4):949-956.
Yu W, Han Y, Wu X, et al. A split-face randomized controlled trial of treatment with broadband light for enlarged facial pores [published online ahead of print December 4, 2019]. J Dermatolog Treat 2019. 1-5. https://doi.org/10.1080/09546634.2019.1698701
Wat H, Yee-Nam Shek S, Yeung CK, Chan HH. Efficacy and safety of picosecond 755-nm alexandrite laser with diffractive lens array for non-ablative rejuvenation in Chinese skin. Lasers Surg Med 2019;51(1):8-13.
Kwon HH, Choi SC, Lee WY, Jung JY, Park GH. Clinical and histological evaluations of enlarged facial skin pores after low energy level treatments with fractional carbon dioxide laser in korean patients. Dermatol Surg 2018;44(3):405-412.
El-Domyati M, Abd-El-Raheem T, Medhat W, Abdel-Wahab H, Al Anwer M. Multiple fractional erbium:yttrium-aluminum-garnet laser sessions for upper facial rejuvenation: Clinical and histological implications and expectations. J Cosmet Dermatol 2014;13(1):30-37.
Khatri KA, Ross V, Grevelink JM, Magro CM, Anderson RR. Comparison of erbium:YAG and carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol 1999;135(4):391-397.
Suh DH, Chang KY, Lee SJ, et al. Treatment of dilated pores with 1410-nm fractional erbium-doped fiber laser. Lasers Med Sci 2015;30(3):1135-1139.
El-Domyati M, Abd-El-Raheem T, Abdel-Wahab H, et al. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: An objective evaluation. J Am Acad Dermatol 2013;68(1):103-112.